×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of ...
PR Newswire
PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company), a clinical-stage pharmaceutical company with a broad...
8 hours ago
Moleculin Biotech Initiates Phase 2 Glioblastoma Treatment Study - TipRanks.com
Tipranks
An announcement from Moleculin Biotech (MBRX) is now available. Moleculin Biotech, Inc. has launched an exciting Phase 2 study to evaluate the efficacy of...
8 hours ago
Earnings call: Moleculin Biotech optimistic on Annamycin's future
Investing.com
Moleculin Biotech, Inc. (NASDAQ:MBRX), in its first quarter 2024 earnings call, highlighted significant progress in the development of its...
1 day ago
Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
KGET.com
Recently announced interim data from ongoing MB-106 study demonstrating Annamycin in combination with Cytarabine (AnnAraC) achieves CRc rate...
2 days ago
Moleculin Biotech Inc (MBRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances and Financial Health
GuruFocus
R&D Expense: $4.3 million for the quarter, down from $5.7 million in the same period last year.G&A Expense: $2.4 million for the quarter,...
1 day ago
Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
WATE 6 On Your Side
Patent, once issued, will provide composition protection through 2040, with potential for additional term extension.
6 days ago
Moleculin Biotech, Inc. Completes Initial Public Offering
Yahoo News Singapore
Moleculin Biotech, Inc. today announced that it closed an initial public offering of 1540026 common shares for gross proceeds of $9240156.
3 days ago
Moleculin Biotech Updates Investors with Corporate Presentation - TipRanks.com
Tipranks
An update from Moleculin Biotech (MBRX) is now available. Moleculin Biotech, Inc. is sharing a corporate presentation on its website, which provides an...
1 day ago
Q1 2024 Moleculin Biotech Inc Earnings Call Transcript
GuruFocus
May 13, 2024 / 12:30PM GMTOperator Hello, and welcome to the Molecular and biotech First Quarter 2020 for quarterly update conference call...
1 day ago
Moleculin Biotech reports Q1 EPS ($2.02) vs. ($4.13) last year - TipRanks.com
Tipranks
As of March 31, the company had cash and cash equivalents of $16.8M and believes that this cash is sufficient to meet its projected operating requirements,...
1 day ago